Xov Xwm Kev Lag Luam

Tsis ntev los no, ib txoj kev tshawb fawb qhia txog cov txiaj ntsig zoo ntawm CD7-targeted chimeric antigen receptor (CAR) T cell therapy hauv kev kho cov neeg mob uas rov qab mob lossis tsis kho tau T-cell acute lymphoblastic leukemia (T-ALL) thiab T-cell lymphoblastic lymphoma (T-LBL).

Lub Rooj Sib Tham Txhua Xyoo 66th ntawm American Society of Hematology (ASH) yuav muaj nyob rau txij lub Kaum Ob Hlis 7-10, 2024, ntawm San Diego Convention Center, uas qhia txog kev tshawb fawb tshiab thiab kev nce qib hauv hematology.

Txawm hais tias muaj kev cov nyom hauv kev lag luam thiab kev lag luam, CAR-T therapy cov kev txwv tau raug daws los ntawm txoj hauv kev tshiab zoo: Tumor-Infiltrating Lymphocyte (TIL) therapy. Qhov kev tshawb pom no qhia txog lub sijhawm tshiab hauv kev sib ntaus tawm tsam cov qog nqaij hlav khov kho.

Ib txoj kev kho mob tshiab rau mob qog noj ntshav kuj tseem yuav kho tau thiab pib dua lub cev tiv thaiv kab mob kom rov zoo li qub lossis tej zaum yuav kho tau qee yam kab mob autoimmune.

Lub Rooj Sib Tham Txhua Xyoo 65th ntawm American Society of Hematology (ASH) tau muaj nyob rau hnub tim 9 txog 12 Lub Kaum Ob Hlis 2023, hauv San Diego, Tebchaws Meskas. Raws li lub rooj sib tham loj tshaj plaws thiab muaj txiaj ntsig tshaj plaws hauv ntiaj teb txog kev kawm txog ntshav, nws nyiam ntau txhiab tus kws tshaj lij thiab cov kws tshawb fawb los ntawm thoob plaws ...